Clinical trial
Normal Saline Versus Heparin Intermittent Flushing for the Prevention of Occlusion in Port-a-Cath: Randomized Controlled Trial
NCT05707936 is registered in ClinicalTrials.gov with Chang Gung Memorial Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Normal Saline Versus Heparin Intermittent Flushing for the Prevention of Occlusion in Port-a-Cath: Randomized Controlled Trial
- Lead sponsor
- Chang Gung Memorial Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- February 1, 2023
- Completion date
- December 31, 2023
- Enrollment
- 192 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
heparin lock, normal saline, port-a-cath occlusion